689: Be the Bridge | Terry Coelho, CFO, BioDelivery Sciences International (BDSI)
Within 4 months of her 2019 arrival inside BDSI’s CFO office, Terry Coelho had spearheaded a product acquisition and managed a successful equity raise—two finance milestones that would produce generous sales tailwinds for the specialty pharmaceutical firm.
BDSI would experience 100% net sales growth in 2019, followed by 40% net sales growth in 2020. Such sales momentum recently led BDSI to issue a press release praising its “new commercial team” and at the same time announcing that Coelho’s CFO title would now include the designation “executive vice president.”
For Coelho, a seasoned finance…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.